Fisher & Paykel Healthcare Corporation Limited
(ASX:FPH) has reported a record annual result and forecast earnings growth in the year ahead.
The medical device manufacturer’s net profit lifted 17 per cent to $NZ113.2 million, or about $AUD106.2 million, in the year to the end of March.
CEO Michael Daniell says the company is pleased with the record results which he believes demonstrate the success of a consistent growth strategy.
Looking ahead Mr Daniell says this strategy will continue to deliver robust revenue growth in the current year.
A final dividend of 8 cents per share has been declared, rising 14 per cent from the year before.
